The effect of granulocyte colony-stimulating factor dose and administration interval after allogeneic hematopoietic cell transplantation on early engraftment of neutrophil and platelet

The effect of granulocyte colony-stimulating factor dose and administration interval after allogeneic hematopoietic cell transplantation on early engraftment of neutrophil and platelet

Background: Hematopoietic stem cell transplantation (HSCT) is one of the treatments for hematologic malignancies. Numerous factors affect the HSCT outcome. The purpose of this study was to investigate the effect of post-HSCT administration of granulocyte colony-stimulating factor (post-G-CSF) on ear...

Full description

Bibliographic Details
Main Authors: Bonakchi, H. (Author), Hajifathali, A. (Author), Mirfakhraie, R. (Author), Noorazar, L. (Author), Parkhideh, S. (Author), Roshandel, E. (Author), Salimi, M. (Author), Sankanian, G. (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
acute lymphoblastic leukemia
acute myeloid leukemia
adult
Adult
allogeneic hematopoietic stem cell transplantation
allograft
Allografts
allo-HSCT
Antigens, CD34
Article
Blood Platelets
busulfan
CD3 antigen
CD3 Complex
CD34 antigen
cell count
cyclophosphamide
donor
dose response
drug dose reduction
drug effect
early engraftment
engraftment
female
Female
fludarabine
granulocyte colony stimulating factor
Granulocyte Colony-Stimulating Factor
health care facility
hematologic disease
Hematologic Neoplasms
hematopoietic stem cell transplantation
Hematopoietic Stem Cell Transplantation
human
Humans
Iran
lomustine
major clinical study
male
Male
myeloablative conditioning
neutrophil
Neutrophils
platelet
post-G-CSF
procedures
reduced intensity conditioning
retrospective study
risk factor
Risk Factors
statistical analysis
thrombocyte
thymocyte antibody
time
time factor
Time Factors
Tissue Donors
treatment outcome
Treatment Outcome
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items